236
T. Zhang et al.
63. Zhang K, Yang Q, Huang W, Wang K, Zhu X, Xie M (2019) Detection of HIV-1 ribonuclease
H activity in single-cell by using RNA mimics green fluorescent protein based biosensor. Sens
Actuators B Chem 281:439–444
64. Fatin MF, Rahim Ruslinda A, Gopinath SCB, Arshad MKM, Hashim U, Lakshmipriya T,
Tang T-H, Kamarulzaman A (2019) Co-ordinated split aptamer assembly and disassembly on
Gold nanoparticle for functional detection of HIV-1 tat. Process Biochem 79:32–39
65. Wang L, Zhou H, Liu B, Zhao C, Fan J, Wang W, Tong C (2017) Fluorescence assay for
ribonuclease H based on Nonlabeled substrate and DNAzyme assisted cascade amplification.
Anal Chem 89(20):11014–11020
66. Deng X, Wang C, Gao Y, Li J, Wen W, Zhang X, Wang S (2018) Applying strand displacement amplification to quantum dots-based fluorescent lateral flow assay strips for HIV-DNA
detection. Biosens Bioelectron 105:211–217
67. DeStefano JJ, Alves Ferreira-Bravo I (2018) A highly sensitive aptamer-based HIV reverse
transcriptase detection assay. J Virol Methods 257:22–28
68. Chang CC, Chen CY, Chuang TL, Wu TH, Wei SC, Liao H, Lin CW (2016) Aptamer-based
colorimetric detection of proteins using a branched DNA cascade amplification strategy and
unmodified gold nanoparticles. Biosens Bioelectron 78:200–205
69. Wang H, Liang G (2015) Epidemiology of Japanese encephalitis: past, present, and future
prospects. Ther Clin Risk Manag 11:435–448
70. Whitley RJ (1990) Viral Encephalitis. N Engl J Med 323(4):242–250
71. Ray D, Shah A, Tilgner M, Guo Y, Zhao YW, Dong HP, Deas TS, Zhou YS, Li HM, Shi PY
(2006) West Nile Virus 5’-Cap Structure Is Formed by Sequential Guanine N-7 and Ribose
2’-O Methylations by Nonstructural Protein 5. J Virol 80(17):8362–8370
72. Han SR, Lee SW (2017) Inhibition of Japanese encephalitis virus (JEV) replication by specific
RNA aptamer against JEV methyltransferase. Biochem Biophys Res Commun 483(1):687–
693
73. Kang J, Lee MS, Watowich SJ, Gorenstein DG (2007) Combinatorial selection of a RNA
thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein. FEBS Lett
581(13):2497–2502
74. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human
monoclonal antibody. Emerg Microbes Infect 9(1):382–385
75. Song Yl, Song J, Wei XY, Huang MJ, Sun M, Zhu L, Lin BQ, Shen HC, Zhu Z, Yang
CY (2020) Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2
Spike Glycoprotein. Anal Chem 14(92):9895–9900
76. Ung COL (2020) Community pharmacist in public health emergencies: quick to action against
the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm 16(4):583–586
77. Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish
ZA, Drosten C, Zumla A, Petersen E (2020) The continuing 2019-nCoV epidemic threat of
novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan,
China. Int J Infect Dis 91:264–266
78. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan
JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science
367(6483):1260
79. Nik Kamarudin NAA, Mohammed NA, Mustaffa KMF (2017) Aptamer technology: adjunct
therapy for malaria. Biomedicines 5(1):1
80. World Health Organization (2020) World malaria report 2019
81. Fatih FA, Staines HM, Siner A, Ahmed MA, Woon LC, Pasini EM, Kocken CHM, Singh B,
Cox-Singh J, Krishna S (2013) Susceptibility of human Plasmodium knowlesi infections to
anti-malarials. Malar J 12(1):425
82. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, Lin K, Kyaw MP, Plewes
K, Faiz MA, Dhorda M, Cheah PY, Pukrittayakamee S, Ashley EA, Anderson TJC, Nair S,
McDew-White M, Flegg JA, Grist EPM, Guerin P, Maude RJ, Smithuis F, Dondorp AM,
Day NPJ, Fo N, White NJ, Woodrow CJ (2015) Spread of artemisinin-resistant Plasmodium
Précédent

- 246/470

Suivant